Dong Joon Kim

13.9k total citations · 2 hit papers
230 papers, 5.1k citations indexed

About

Dong Joon Kim is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Dong Joon Kim has authored 230 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 138 papers in Epidemiology, 91 papers in Hepatology and 65 papers in Molecular Biology. Recurrent topics in Dong Joon Kim's work include Liver Disease Diagnosis and Treatment (121 papers), Hepatitis B Virus Studies (45 papers) and Liver Disease and Transplantation (44 papers). Dong Joon Kim is often cited by papers focused on Liver Disease Diagnosis and Treatment (121 papers), Hepatitis B Virus Studies (45 papers) and Liver Disease and Transplantation (44 papers). Dong Joon Kim collaborates with scholars based in South Korea, United States and Nigeria. Dong Joon Kim's co-authors include Ki Tae Suk, Gwang Ho Baik, Chang Seok Bang, Seung Ha Park, Soon Koo Baik, Young Joo Yang, Moon Young Kim, Haripriya Gupta, Jin Bong Kim and Sang Hak Han and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Dong Joon Kim

221 papers receiving 5.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Natural Bis-Benzylisoquinoline Alkaloids-Tetrandrine, Fangchinoline, and Cepharanthine, Inhibit Human Coronavirus OC43 Infection of MRC-5 Human Lung Cells

2019 215 citations Dong Joon Kim et al. profile →
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation

2024 69 citations Haripriya Gupta, Jin‐Ju Jeong et al. Gut Microbes profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dong Joon Kim South Korea	37	2.4k	1.7k	1.4k	852	548	230	5.1k
Ki Tae Suk South Korea	39	2.4k 1.0×	1.6k 0.9×	1.5k 1.1×	1.2k 1.4×	558 1.0×	208	5.0k
Vanessa Stadlbauer Austria	41	2.3k 0.9×	2.1k 1.3×	1.6k 1.1×	1.2k 1.4×	440 0.8×	184	5.6k
Andrea De Gottardi Switzerland	34	2.8k 1.1×	2.3k 1.4×	1.3k 0.9×	1.2k 1.4×	392 0.7×	99	4.9k
Oren Shibolet Israel	40	2.5k 1.0×	1.4k 0.9×	1.1k 0.7×	868 1.0×	311 0.6×	153	5.6k
M. Eric Gershwin United States	50	2.4k 1.0×	2.6k 1.5×	1.5k 1.0×	1.5k 1.7×	460 0.8×	142	8.3k
Norberto C. Chávez‐Tapia Mexico	36	2.9k 1.2×	1.7k 1.0×	703 0.5×	1.2k 1.4×	374 0.7×	194	4.7k
Javier Crespo Spain	39	3.7k 1.5×	2.3k 1.4×	1.4k 1.0×	932 1.1×	526 1.0×	365	7.1k
Jordi Camps Spain	46	1.7k 0.7×	934 0.6×	1.4k 1.0×	1.2k 1.5×	269 0.5×	252	7.1k
Francesca Romana Ponziani Italy	39	2.1k 0.9×	1.8k 1.1×	1.8k 1.3×	1.0k 1.2×	276 0.5×	178	5.1k
Grace L. Su United States	49	3.6k 1.5×	2.7k 1.6×	1.5k 1.0×	1.2k 1.4×	755 1.4×	166	8.1k

Countries citing papers authored by Dong Joon Kim

Since Specialization

Citations

This map shows the geographic impact of Dong Joon Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dong Joon Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dong Joon Kim more than expected).

Fields of papers citing papers by Dong Joon Kim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dong Joon Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dong Joon Kim. The network helps show where Dong Joon Kim may publish in the future.

Co-authorship network of co-authors of Dong Joon Kim

This figure shows the co-authorship network connecting the top 25 collaborators of Dong Joon Kim. A scholar is included among the top collaborators of Dong Joon Kim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dong Joon Kim. Dong Joon Kim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ganesan, Raja, Durairaj Thirumurugan, Saranya Vinayagam, et al.. (2025). A critical review of microbiome-derived metabolic functions and translational research in liver diseases. Frontiers in Cellular and Infection Microbiology. 15. 1488874–1488874. 4 indexed citations

Choi, Jieun, Ye Rin Choi, Soon H Song, et al.. (2025). Phocaeicola dorei ameliorates progression of steatotic liver disease by regulating bile acid, lipid, inflammation and proliferation. Gut Microbes. 17(1). 2539448–2539448. 3 indexed citations

Kim, Jung Hee, Jang Han Jung, Sung Eun Kim, et al.. (2023). Serum S100B Levels in Patients with Liver Cirrhosis and Hepatic Encephalopathy. Diagnostics. 13(3). 333–333. 1 indexed citations

Park, Ji Won, Jung Hee Kim, Sung Eun Kim, et al.. (2022). Primary Biliary Cholangitis and Primary Sclerosing Cholangitis: Current Knowledge of Pathogenesis and Therapeutics. Biomedicines. 10(6). 1288–1288. 33 indexed citations

Agarwal, Kosh, Jia Xu, Edward Gane, et al.. (2022). Safety, pharmacokinetics and antiviral activity of ABI‐H2158, a hepatitis B virus core inhibitor: A randomized, placebo‐controlled phase 1 study. Journal of Viral Hepatitis. 30(3). 209–222. 4 indexed citations

Oh, Ki‐Kwang, Ickwon Choi, Haripriya Gupta, et al.. (2022). New insight into gut microbiota-derived metabolites to enhance liver regeneration via network pharmacology study. Artificial Cells Nanomedicine and Biotechnology. 51(1). 1–12. 7 indexed citations

Yim, Hyung Joon, Won Kim, Sang Hoon Ahn, et al.. (2021). Besifovir therapy improves hepatic histology and reduces covalently closed circular DNA in chronic hepatitis B patients. Journal of Gastroenterology and Hepatology. 37(2). 378–386. 5 indexed citations

Yuen, Man‐Fung, Edward Gane, Dong Joon Kim, et al.. (2019). Antiviral Activity, Safety, and Pharmacokinetics of Capsid Assembly Modulator NVR 3-778 in Patients with Chronic HBV Infection. Gastroenterology. 156(5). 1392–1403.e7. 117 indexed citations

Kim, Tae Yeob, Ki Tae Suk, Soung Won Jeong, et al.. (2019). The New Cutoff Value of the Hepatic Venous Pressure Gradient on Predicting Long-Term Survival in Cirrhotic Patients. Journal of Korean Medical Science. 34(33). e223–e223. 4 indexed citations

10.

Cho, Yuri, et al.. (2018). Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial. Trials. 19(1). 696–696. 13 indexed citations

11.

Kim, Sung Eun, Ji Won Park, Byungki Jang, et al.. (2018). Accumulation of citrullinated glial fibrillary acidic protein in a mouse model of bile duct ligation-induced hepatic fibrosis. PLoS ONE. 13(8). e0201744–e0201744. 14 indexed citations

12.

Kim, Jong‐Eun, Joe Eun Son, Hyein Jeong, et al.. (2015). A Novel Cinnamon-Related Natural Product with Pim-1 Inhibitory Activity Inhibits Leukemia and Skin Cancer. Cancer Research. 75(13). 2716–2728. 30 indexed citations

13.

Bang, Chang Seok, Gwang Ho Baik, Jong Hyeok Kim, et al.. (2014). Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. Scandinavian Journal of Gastroenterology. 49(9). 1051–1057. 9 indexed citations

14.

Kim, Hyoung Su, Woon Geon Shin, Kyung Ho Kim, et al.. (2014). Phylogenetic Analyses of HBV Pre-S/S Genes in Mother-Child Pairs with Long-Term Infection by Presumed Vertical Transmission. Journal of Korean Medical Science. 29(4). 564–564. 3 indexed citations

15.

Lee, Sungyoung, Jaeho Yoon, Mee‐Hyun Lee, et al.. (2012). The Role of Heterodimeric AP-1 Protein Comprised of JunD and c-Fos Proteins in Hematopoiesis. Journal of Biological Chemistry. 287(37). 31342–31348. 26 indexed citations

16.

Park, Seung Ha, Chang‐Hoon Kim, Dong Joon Kim, et al.. (2011). Usefulness of Multiple Biomarkers for the Prediction of Significant Fibrosis in Chronic Hepatitis B. Journal of Clinical Gastroenterology. 45(4). 361–365. 23 indexed citations

17.

Ahn, Eun Hee, Dae Won Kim, Hye Won Kang, et al.. (2010). Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicology. 276(3). 192–197. 45 indexed citations

18.

Kim, Ji Hyun, et al.. (2010). Multilaboratory Assessment of Variations in Spectrophotometry-Based DNA Quantity and Purity Indexes. Biopreservation and Biobanking. 8(4). 187–192. 11 indexed citations

19.

Kim, Byoung‐Ho, Dong Joon Kim, Hana Yang, et al.. (2009). A case of fulminant hepatic failure due to cyproterone acetate in a patient with cryptogenic liver cirrhosis. The Korean Journal of Internal Medicine. 77. 31–35. 1 indexed citations

20.

Kim, Dong Joon, et al.. (2007). The Survey for the Actual Condition of Drug Medication and Development of Health Care Cost Associated with Toxic Liver Injury in Korean. Clinical and Molecular Hepatology. 13(1). 34–43. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact